Antiplatelet Secondary Prevention International Randomised trial after INtracerebral haemorrhaGe (ASPIRING): a pragmatic, randomised, parallel group, open, superiority, phase 3 GCRFF multinational clinical trial. Application for i

Project Details

StatusActive
Effective start/end date1/02/2431/07/30

Funding

  • British Heart Foundation: £2,171,693.88
  • British Heart Foundation: £162,242.72